Kolb, H. C., Finn, M. G. & Sharpless, K. B. Click chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. 40, 2004–2021 (2001).

Article  CAS  Google Scholar 

Rostovtsev, V. V., Green, L. G., Fokin, V. V. & Sharpless, K. B. A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective ‘ligation’ of azides and terminal alkynes. Angew. Chem. Int. Ed. 41, 2596–2599 (2002).

Article  CAS  Google Scholar 

Dong, J., Krasnova, L., Finn, M. G. & Sharpless, K. B. Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry. Angew. Chem. Int. Ed. 53, 9430–9448 (2014).

Article  CAS  Google Scholar 

Tornøe, C. W., Christensen, C. & Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 67, 3057–3064 (2002).

Article  PubMed  Google Scholar 

Paioti, P. H. S. et al. Click processes orthogonal to CuAAC and SuFEx forge selectively modifiable fluorescent linkers. Nat. Chem. 16, 426–436 (2024).

Article  CAS  PubMed  Google Scholar 

Homer, J. A. et al. Sulfur fluoride exchange. Nat. Rev. Methods Primers 3, 58 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Békés, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181–200 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Liu, J. et al. Cancer selective target degradation by folate-caged PROTACs. J. Am. Chem. Soc. 143, 7380–7387 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, Y. et al. Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation. Chem. Soc. Rev. 51, 5330–5350 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imaide, S. et al. Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity. Nat. Chem. Biol. 17, 1157–1167 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, K. L. & Crews, C. M. PROTACs: past, present and future. Chem. Soc. Rev. 51, 5214–5236 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao, J. et al. Radical-mediated click-clip reactions. Science 385, 1354–1359 (2024).

Article  CAS  PubMed  Google Scholar 

Yamazaki, C. M. et al. Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nat. Commun. 12, 3528 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu, Q. et al. Bioorthogonal chemistry for prodrug activation in vivo. Chem. Soc. Rev. 52, 7737–7772 (2023).

Article  CAS  PubMed  Google Scholar 

Min, Q. & Ji, X. Bioorthogonal bond cleavage chemistry for on-demand prodrug activation: opportunities and challenges. J. Med. Chem. 66, 16546–16567 (2023).

Article  CAS  PubMed  Google Scholar 

Kondengadan, S. M. et al. Click chemistry and drug delivery: a bird’s-eye view. Acta Pharma. Sin. B 13, 1990–2016 (2023).

Article  CAS  Google Scholar 

Lei, K. et al. Research progress in the application of bile acid-drug conjugates: a ‘trojan horse’ strategy. Steroids 173, 108879 (2021).

Article  CAS  PubMed  Google Scholar 

Dean, T. T., Jelú-Reyes, J., Allen, A. & Moore, T. W. Peptide-drug conjugates: an emerging direction for the next generation of peptide therapeutics. J. Med. Chem. 67, 1641–1661 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Askari Rizvi, S. F., Zhang, L., Zhang, H. & Fang, Q. Peptide-drug conjugates: design, chemistry, and drug delivery system as a novel cancer theranostic. ACS Pharmacol. Transl. Sci. 7, 309–334 (2024).

Article  Google Scholar 

Meng, F., Jang, H., Jung, B. & Hoveyda, A. H. Cu-catalyzed chemoselective preparation of 2-(pinacolato)boron-substituted allylcopper complexes and their in situ site-, diastereo-, and enantioselective additions to aldehydes and ketones. Angew. Chem. Int. Ed. 52, 5046–5051 (2013).

Article  CAS  Google Scholar 

Sies, H. & Jones, D. P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Bio. 21, 363–383 (2020).

Article  CAS  Google Scholar 

Sies, H. et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat. Rev. Mol. Cell Bio. 23, 499–515 (2022).

Article  CAS  Google Scholar 

Pelicano, H., Carney, D. & Huang, P. ROS stress in cancer cells and therapeutic implications. Drug Resist. Updates 7, 97–110 (2004).

Article  CAS  Google Scholar 

Paravicini, T. M. & Touyz, R. M. Redox signaling in hypertension. Cardiovasc. Res. 71, 247–258 (2006).

Article  CAS  PubMed  Google Scholar 

Sies, H. Role of metabolic H2O2 generation: redox signaling and oxidative stress. J. Biol. Chem. 289, 8733–8741 (2014).

Article  Google Scholar 

Wu, Y. et al. An inorganic prodrug, tellurium nanowires with enhanced ROS generation and GSH depletion for selective cancer therapy. Chem. Sci. 10, 7068–7075 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashman, N. et al. Peroxide-cleavable linkers for antibody–drug conjugates. Chem. Commun. 59, 1841–1844 (2023).

Article  CAS  Google Scholar 

Hull, M. A., Gardner, S. H. & Hawcroft, G. Activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer. Cancer Treat. Rev. 29, 309–320 (2003).

Article  CAS  PubMed  Google Scholar 

Shagufta & Ahmad, I. Tamoxifen a pioneering drug: an update on the therapeutic potential of tamoxifen derivatives. Eur. J. Med. Chem. 143, 515–531 (2018).

Article  CAS  PubMed  Google Scholar 

Kolate, A. et al. PEG—a versatile conjugating ligand for drugs and drug delivery systems. J. Control. Release 192, 67–81 (2014).

Article  CAS  PubMed  Google Scholar 

Sun, S. et al. Phosphorus fluoride exchange: multidimensional catalytic click chemistry from phosphorus connective hubs. Chem 9, 2128–2143 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao, G., Xu, Z. P. & Li, L. Manipulating extracellular tumour pH: an effective target for cancer therapy. RSC Adv. 8, 22182–22192 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Michl, J. et al. Acid-adapted cancer cells alkalinize their cytoplasm by degrading the acid-loading membrane transporter anion exchanger 2, SLC4A2. Cell Rep. 42, 112601 (2023).

Article